Navigation Links
Dynatronics Selected for Inclusion in RB Milestone Portfolio
Date:3/16/2011

SALT LAKE CITY, March 16, 2011 /PRNewswire/ -- Dynatronics Corporation (Nasdaq: DYNT) announced that it has been selected for inclusion in the RB Milestone Portfolio, a group of companies selected by RB Milestone Group, LLC ("RBMG"), to be introduced to the market via a combination of traditional and innovative analytical and communication strategies including equity research, The Portal Network™, and non-deal roadshows, with a focus on the healthcare, mining, energy, and technology sectors.

The Portal Network™, RBMG's web-based platform, provides cutting-edge communications solutions that are believed by RBMG to outperform more traditional efforts. In addition to an array of proprietary equity research, RBMG members, including corporate executives and sophisticated investors, also have access to the interactive tools intended to assist them to communicate more efficiently with other key industry players.

News and discussions pertaining to Dynatronics can now be followed at RBMG's Portal Network™ by the following link: http://www.rbmilestone.com/register.

About RB Milestone Group

RB Milestone Group (RBMG) is a Wall Street-based equity research firm that provides a variety of cutting-edge equity research solutions through its proprietary platform, The Portal Network™. This web-based platform is a premier interactive research hub, which, according to RBMG, has proven to outperform the effectiveness of traditional research solutions and coverage communications efforts. RBMG's network presently totals approximately 1,100 flagship institutional and high net worth members. RBMG only accepts a select number of companies into their coverage network in a given year, and those who are admitted into the RB Milestone Portfolio are deemed by RBMG to be significantly undervalued on a fundamental and technical analysis basis.

About Dynatronics

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.  

This press release contains forward-looking statements. Those statements include references to future events and similar statements. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2010.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
2. Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status
3. Dynatronics Regains Compliance With NASDAQ
4. Dynatronics to Release Second Quarter Results Monday, February 1, 2010; Conference Call Set for 1:30 p.m. ET
5. Dynatronics to Release First Quarter Results Friday, November 13, 2009; Conference Call Set for 1:30 p.m. ET
6. Dynatronics Announces Increases in Pre-tax Profits and Net Income for the Quarter Ended December 31, 2009
7. Dynatronics Announces Positive Financial Results for Quarter
8. Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc.
9. Dynatronics Receives 180-Day NASDAQ Extension
10. Dynatronics Named Sole-Source Supplier to Benchmark Physical Therapy
11. Dynatronics to Release Third Quarter Results Monday, May 17, 2010; Conference Call Set for 1:30 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... Medicare doesn’t have the authority ... gouging for their prescription drugs, according to a new comparison of drug plans ... our behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s ...
(Date:9/20/2017)... ... ... “Finn Mouseson”: follows the exciting story of a mouse as the need for adventure ... journey that will show that friends are to be gathered but home is always ... Melody Gersonde-Mickelson, who has earned a bachelor’s degree in Fine Arts from the University ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Financial Favor of God; Second Edition”: a ... Second Edition” is the creation of published author, Brooks Rathell. , “We typically hear ... to you about the financial favor of God. Not only does it exist, but ...
(Date:9/19/2017)... NY (PRWEB) , ... September 19, 2017 , ... ... announced today the addition of strategic marketing leader, Denise Flannery, to its strategic ... Marketing, Brand and Management Consultant, Denise will work with clients across different industries ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... will return to Texas as a part of its national Swirl: A Wine ...
Breaking Medicine News(10 mins):